Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors

被引：0
|
作者：
Maurizio Lucchesi
Milena Guidi
Carla Fonte
Silvia Farina
Patrizio Fiorini
Claudio Favre
Maurizio de Martino
Iacopo Sardi
机构：
[1] Meyer Children’s University Hospital,Neuro
[2] Meyer Children’s University Hospital,Oncology Unit, Department of Pediatric Oncology
[3] University of Florence,Neonatal Intensive Care Unit, Department of Pediatrics
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 77卷
关键词：
High-dose methotrexate; Pediatric brain tumors; Early infants; Chemotherapy toxicities; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 864
页数：7
相关论文
共 50 条
  • [1] Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors
    Lucchesi, Maurizio
    Guidi, Milena
    Fonte, Carla
    Farina, Silvia
    Fiorini, Patrizio
    Favre, Claudio
    de Martino, Maurizio
    Sardi, Iacopo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) : 857 - 864
  • [2] PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE IN INFANTS AGED LESS THAN 12 MONTHS TREATED FOR BRAIN TUMORS
    Lucchesi, Maurizio
    Guidi, Milena
    Fonte, Carla
    Farina, Silvia
    Favre, Claudio
    Genitori, Lorenzo
    Sardi, Iacopo
    NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [3] Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors
    Guidi, Milena
    Giunti, Laura
    Buccoliero, Anna Maria
    Santi, Mariarita
    Spacca, Barbara
    De Masi, Salvatore
    Genitori, Lorenzo
    Sardi, Iacopo
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [4] EVALUATION OF CLINICAL AND MOLECULAR FEATURES IN INFANTS AGED LESS THAN 12 MONTHS TREATED FOR AGGRESSIVE BRAIN TUMORS
    Facchini, Ludovica
    Guidi, Milena
    Lucchesi, Maurizio
    Buccoliero, Anna Maria
    Giunti, Laura
    Mocheo, Carla
    Genitori, Lorenzo
    Sardi, Iacopo
    NEURO-ONCOLOGY, 2017, 19 : 19 - 19
  • [5] Pharmacokinetic Profile of High-Dose Methotrexate in Children Aged Less Than 12 Months Affected by Brain Tumour
    Lucchesi, M.
    Farina, S.
    Fonte, C.
    Guidi, M.
    Facchini, L.
    Favre, C.
    Sardi, I.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S141 - S141
  • [6] POPULATION PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE IN INFANTS WITH MALIGNANT BRAIN TUMORS
    Turner, David
    Wright, Karen
    Broniscer, Alberto
    Robinson, Giles
    Qaddoumi, Ibrahim
    Armstrong, Greg
    Gajjar, Amar
    Stewart, Clinton
    NEURO-ONCOLOGY, 2014, 16 : 13 - 13
  • [7] POPULATION PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE IN INFANTS WITH BRAIN TUMORS.
    Roberts, J.
    Lin, T.
    Huang, J.
    Onar-Thomas, A.
    Panetta, J.
    Daryani, V.
    Robinson, G.
    Broniscer, A.
    Gajjar, A.
    Stewart, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S45 - S45
  • [8] Pharmacokinetics of High-Dose Methotrexate in Infants Treated for Acute Lymphoblastic Leukemia
    Lonnerholm, Gudmar
    Valsecchi, Maria Grazia
    De Lorenzo, Paola
    Schrappe, Martin
    Hovi, Liisa
    Campbell, Myriam
    Mann, Georg
    Janka-Schaub, Gritta
    Li, Chi-Kong
    Stary, Jan
    Hann, Ian
    Pieters, Rob
    PEDIATRIC BLOOD & CANCER, 2009, 52 (05) : 596 - 601
  • [9] DISPOSITION OF HIGH-DOSE METHOTREXATE IN VERY YOUNG INFANTS WITH MALIGNANT BRAIN TUMORS
    Daryani, V.
    Wright, K.
    Broniscer, A.
    Robinson, G.
    Qaddoumi, I.
    Armstrong, G.
    Gajjar, A.
    Stewart, C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S215 - S215
  • [10] Intravenous high-dose methotrexate (IVHDM) rather than intraventricular methotrexate for pediatric brain tumors
    Cohen, Ian J.
    Toledano, Helen
    Shuper, Avinoam
    Kornreich, Liorah
    Michowitz, Shalom
    Yaniv, Isaac
    NEURO-ONCOLOGY, 2008, 10 (03) : 510 - 510
12345